CIK 0001429260
- Non-accelerated filer
- Smaller reporting company
Fortress Biotech, Inc.
Sign in to watch- Ticker
- FBIO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 205157386
- Phone
- +1 781-652-4500
- Business address
- 1111 KANE CONCOURSE, SUITE 301, BAY HARBOR ISLANDS, FL, 33154
- Former names
- Fortress Biotech, Inc., CORONADO BIOSCIENCES INC
Securities
- FBIO Common Stock Nasdaq
- FBIOP 9.375% Series A Cumulative Redeemable Perpetual Preferred Stock Nasdaq
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market buy Chairman and CEO bought 20,000 shares at $5.71 ($114,200)
- 4 Derivatives Options or other derivatives
- 4 Open-market buy President and CEO bought 3,811 shares at $4.02 ($15,320)
- 4 Open-market buy Director bought 3,811 shares at $4.02 ($15,320)
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 4 Open-market buy Director bought 200,000 shares at $5.00 ($1,000,000)
- 4 Open-market buy Chief Financial Officer bought 10,000 shares at $5.00 ($50,000)
- 4 Open-market buy Hehenberger Karin M. bought 20,000 shares at $5.00 ($100,000)
- 4 Open-market buy President and CEO bought 10,000 shares at $5.00 ($50,000)
- 4 Open-market buy EVP & COO bought 5,000 shares at $5.00 ($25,000)
- 4 Open-market buy Director bought 25,000 shares at $5.00 ($125,000)
- 4 Open-market buy Director bought 10,000 shares at $5.30 ($52,968)
- 4 Open-market buy SVP & Chief Accounting Officer bought 5,000 shares at $5.00 ($25,000)
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
Page 13 of 15 · 291 filings